Vol 18, No 1 (2021)
Case report
Get Citation

Promazine: classic worth rediscovering?

Tomasz Tafliński
DOI: 10.5603/PSYCH.2020.0042
·
Psychiatria 2021;18(1):63-67.

paid access

Vol 18, No 1 (2021)
Prace kazuistyczne

Abstract

Modern psychopharmacology offers an ever wide spectrum of psychotropic drugs that are in practice clinical
adjustment to individual needs. Clinical practice shows that next to pharmaceuticals of the new generation, it is
important to remember about older drugs, well known and embedded in the memory of subsequent generations
psychiatrists. Promazine, among the phenothiazine-derived neuroleptics, is effective in managing the symptoms
of agitation and anxiety of various etiologies, including in elderly patients. Thanks to this, promazine is still widely
used, provided that the patient is properly selected and treated. The purpose of this article is to discuss the
clinical profile of promazine and its principles in psychiatric practice. A case report of a 62-year-old woman with
agitation and anxiety treated with promazine is also provided.

Abstract

Modern psychopharmacology offers an ever wide spectrum of psychotropic drugs that are in practice clinical
adjustment to individual needs. Clinical practice shows that next to pharmaceuticals of the new generation, it is
important to remember about older drugs, well known and embedded in the memory of subsequent generations
psychiatrists. Promazine, among the phenothiazine-derived neuroleptics, is effective in managing the symptoms
of agitation and anxiety of various etiologies, including in elderly patients. Thanks to this, promazine is still widely
used, provided that the patient is properly selected and treated. The purpose of this article is to discuss the
clinical profile of promazine and its principles in psychiatric practice. A case report of a 62-year-old woman with
agitation and anxiety treated with promazine is also provided.

Get Citation

Keywords

promazine, anxiety and agitation treatment, case report

About this article
Title

Promazine: classic worth rediscovering?

Journal

Psychiatria (Psychiatry)

Issue

Vol 18, No 1 (2021)

Article type

Case report

Pages

63-67

DOI

10.5603/PSYCH.2020.0042

Bibliographic record

Psychiatria 2021;18(1):63-67.

Keywords

promazine
anxiety and agitation treatment
case report

Authors

Tomasz Tafliński

References (11)
  1. Kaplan H, Sadock B. Farmakoterapia w zaburzeniach psychicznych. Urban & Partner, Wrocław 1988.
  2. Rzewuska M. Farmakoterapia. In: Bilikiewicz A. ed. Psychiatria, tom III. Urban & Partner, Wrocław 2003.
  3. Chodera A, Herman ZS. Farmakologia kliniczna. Państwowy Zakład Wydawnictw Lekarskich, Warszawa 1993.
  4. Wójcikowski J, Pichard-Garcia L, Maurel P, et al. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine. Br J Pharmacol. 2003; 138(8): 1465–1474.
  5. https://www.drugbank.ca/drugs/DB00420.
  6. Jose PA, Eisner GM, Felder RA. Regulation of blood pressure by dopamine receptors. Nephron Physiol. 2003; 95(2): p19–p27.
  7. Daniel WA, Syrek M, Wójcikowski J. The influence of selective serotonin reuptake inhibitors on the plasma and brain pharmacokinetics of the simplest phenothiazine neuroleptic promazine in the rat. European Neuropsychopharmacology. 1999; 9(4): 337–344.
  8. Promazine Hasco. Charakterystyka produktu leczniczego zatw. 05.2017. www. rejestrymedyczne.csioz.gov.pl (11.05.2020).
  9. Promazine Jelfa. Charakterystyka produktu leczniczego zatw. 05 2014. www. rejestrymedyczne.csioz.gov.pl (11.05.2020).
  10. Cubała WJ, Jakuszkowiak-Wojten K, Burkiewicz A, et al. Promazine in the treatment of delusional parasitosis. Psychiatr Danub. 2011; 23(2): 198–199.
  11. Gareri P, Cotroneo A, Lacava R, et al. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD). Arch Gerontol Geriatr Suppl. 2004(9): 207–215.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl